Novateor Research Laboratories Ltd - 542771 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Board of Directors of the company approved the resolution for Increase in Authorised Capital and subsequent change in MOA and Preferential Allotment of warrants subject to approval of shareholders of the company. Novateor Research Laboratories Ltd - 542771 - Appointment Of Secretarial Auditor And Internal Auditor Of The Company.
Appointment of Secretarial Auditor and Internal Auditor of the company for the F.Y. 2023-24 Novateor Research Laboratories Ltd - 542771 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Bhavya Himanshu Doshi (having DIN: 10255295) as an additional director in the category of Independent Director of the company subject to approval of shareholders in the ensuing shareholders'' meeting. Novateor Research Laboratories Ltd - 542771 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 26, 2023
Outcome of Board Meeting held today i.e. Saturday, August 26, 2023 at the registered office of the company Novateor Research Laboratories Ltd - 542771 - Closure of Trading Window
Pursuant to Intimation given as on August 18, 2023; The Board Meeting of the company rescheduled as on Saturday, August 26, 2023. With respect to that Trading window for trading in the securities of the company already remained closed with effect from August 18, 2023 and will be opened 48 hours after the conclusion of 12th AGM of the company. Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Reschedule Of Board Meeting
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2023 ,inter alia, to consider and approve With reference to Intimation given as on August 18, 2023 and Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the company is rescheduled to be held on Saturday, 26th August, 2023 at registered office of the company to consider the following businesses: 1. To consider and approve the resolution to increase the authorized share capital of the company and subsequent change in the Memorandum of Association of the company. 2. Raising of funds by way of issue of equity shares /convertible warrants to Promoters/ Promoters Group and to persons other than the Promoters/Promoter Group on preferential basis, subject to obtaining the approval of the shareholders of the Company. 3. To consider and approve the matter related to ensuing Annual Meeting of the company. 4. To transact any other businesses with prior approval of chairman. Novateor Research Laboratories Ltd - 542771 - Closure of Trading Window
The trading window for trading in securities of the company will remained closed with effect from Augst 18, 2023 for all the directors, Designed Persons and their immediate relative(s). The trading window will be opened 48 hours after the conclusion of 12th Annual General Meeting of the company. Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 23/08/2023
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/08/2023 ,inter alia, to consider and approve 1. To consider and approve the resolution to increase the authorized share capital of the company and subsequent change in the Memorandum of Association of the company. 2. Raising of funds by way of issue of equity shares /convertible warrants to Promoters/ Promoters Group and to persons other than the Promoters/Promoter Group on preferential basis, subject to obtaining the approval of the shareholders of the Company. 3. To consider and approve the matter related to ensuing Annual Meeting of the company. 4. To transact any other businesses with prior approval of chairman. 1. To consider and approve the resolution to increase the authorized share capital of the company and subsequent change in the Memorandum of Association of the company. 2. Raising of funds by way of issue of equity shares /convertible warrants to Promoters/ Promoters Group and to persons other than the Promoters/Promoter Group on preferential basis, subject to obtaining the approval of the shareholders of the Company. 3. To consider and approve the matter related to ensuing Annual Meeting of the company. 4. To transact any other businesses with prior approval of chairman. Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 23/08/2023
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/08/2023 ,inter alia, to consider and approve 1. To consider and approve the resolution to increase the authorized share capital of the company and subsequent change in the Memorandum of Association of the company. 2. Raising of funds by way of issue of equity shares /convertible warrants to Promoters/ Promoters Group and to persons other than the Promoters/Promoter Group on preferential basis, subject to obtaining the approval of the shareholders of the Company. 3. To consider and approve the matter related to ensuing Annual Meeting of the company. 4. To transact any other businesses with prior approval of chairman. Novateor Research Laboratories Ltd - 542771 - Announcement For Launch Of New Product
Announcement under Para B of Part A of Schedule III of SEBI (LODR) Regulations, 2015 for launch of new product i.e. Smiloshine Sonic Power Power toothbrush.